Adverum Biotechnologies Inc (ADVM)

Long Term Trading Analysis for (ADVM) - Stock Traders Daily

Stock Traders Daily

Truist Financial Reiterates Buy Rating for Adverum Biotechnologies (NASDAQ:ADVM) - MarketBeat

MarketBeat

Monitoring Adverum Biotechnologies Inc (ADVM) after recent insider movements – Knox Daily - Knox Daily

Knox Daily

Is Adial Pharmaceuticals (ADIL) Stock Outpacing Its Medical Peers This Year? - Yahoo Singapore News

Yahoo Singapore News

HC Wainwright Reiterates Buy Rating for Adverum Biotechnologies (NASDAQ:ADVM) - Defense World

Defense World

Down -19.72% in 4 Weeks, Here's Why You Should You Buy the Dip in Adverum Biotechnologies (ADVM) - Yahoo Finance

Yahoo Finance

Adverum Biotechnologies: Q1 Earnings Snapshot - Houston Chronicle

Houston Chronicle

Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights - GlobeNewswire

GlobeNewswire

Are Medical Stocks Lagging Ligand Pharmaceuticals (LGND) This Year? - Yahoo Finance Australia

Yahoo Finance Australia

Why Adverum Biotechnologies (ADVM) Might Surprise This Earnings Season - Yahoo Movies UK

Yahoo Movies UK

Absci (ABSI) to Report Q1 Earnings: Here's What to Expect

Zacks Investment Research

PetIQ (PETQ) Gears Up to Report Q1 Earnings: What's in Store?

Zacks Investment Research

Recursion (RXRX) to Report Q1 Earnings: What's in the Cards?

Zacks Investment Research

ANI Pharmaceuticals (ANIP) to Post Q1 Earnings: What's in Store?

Zacks Investment Research

Viatris (VTRS) to Report Q1 Earnings: Is a Beat in Store?

Zacks Investment Research

Adverum Biotechnologies (NASDAQ:ADVM) Coverage Initiated at HC Wainwright - Defense World

Defense World

Adverum Biotechnologies to Participate in Upcoming May Investor Conferences - GlobeNewswire

GlobeNewswire

Are Options Traders Betting on a Big Move in Adverum (ADVM) Stock? - Yahoo Singapore News

Yahoo Singapore News

Adverum Biotechnologies to Participate in Upcoming May Investor Conferences

GlobeNewswire Inc.

Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Expected to Earn Q1 2024 Earnings of ($1.23) Per Share - MarketBeat

MarketBeat

Adverum Biotechnologies (ADVM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks Investment Research

Adverum Biotechnologies (ADVM) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance

Yahoo Finance

Adverum Biotechnologies a new buy at H.C. Wainwright on wet AMD gene therapy - Seeking Alpha

Seeking Alpha

Daily Progress: Adverum Biotechnologies Inc (ADVM) Gain 3.70, Closing at 9.53 – DWinneX - The Dwinnex

The Dwinnex

Brokerages Set Adverum Biotechnologies, Inc. (NASDAQ:ADVM) PT at $29.00 - MarketBeat

MarketBeat

Adverum Biotechnologies (NASDAQ:ADVM) Price Target Cut to $22.00 - MarketBeat

MarketBeat

Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Short Interest Up 27.0% in April - MarketBeat

MarketBeat

Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific Meeting

GlobeNewswire Inc.

Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific Meeting - GlobeNewswire

GlobeNewswire

Has Adverum Biotechnologies (ADVM) Outpaced Other Medical Stocks This Year?

Zacks Investment Research

Has Adverum Biotechnologies (ADVM) Outpaced Other Medical Stocks This Year? - Yahoo Finance

Yahoo Finance

Down -24.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Adverum Biotechnologies (ADVM)

Zacks Investment Research

Down -24.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Adverum Biotechnologies (ADVM) - Yahoo Finance

Yahoo Finance

Are Medical Stocks Lagging Adverum Biotechnologies (ADVM) This Year?

Zacks Investment Research

How Adverum (ADVM) Stock Stands Out in a Strong Industry

Zacks Investment Research

How Adverum (ADVM) Stock Stands Out in a Strong Industry - Yahoo Finance Australia

Yahoo Finance Australia

Down -28.72% in 4 Weeks, Here's Why Adverum Biotechnologies (ADVM) Looks Ripe for a Turnaround

Zacks Investment Research

Down -28.72% in 4 Weeks, Here's Why Adverum Biotechnologies (ADVM) Looks Ripe for a Turnaround - Yahoo Finance Australia

Yahoo Finance Australia

Down -29.25% in 4 Weeks, Here's Why You Should You Buy the Dip in Adverum Biotechnologies (ADVM)

Zacks Investment Research

3 Biotech Stocks to Buy for the Next Bull Run: March 2024 - Yahoo Finance

Yahoo Finance

Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's ... - Markets Insider

Markets Insider

Is Adverum Biotechnologies (ADVM) Stock Outpacing Its Medical Peers This Year?

Zacks Investment Research

Is Adverum Biotechnologies (ADVM) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Yahoo Finance

Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pipeline Highlights and Corporate Updates

GlobeNewswire Inc.

Adverum Biotechnologies: Q4 Earnings Snapshot - Quartz

Quartz

Comparing Adverum Biotechnologies (NASDAQ:ADVM) & BioCryst Pharmaceuticals (NASDAQ:BCRX) - American Banking and Market News

American Banking and Market News

Adverum Biotechnologies to Participate in the TD Cowen 44th Annual Health Care Conference

GlobeNewswire Inc.

Foley Represents TCGX as Lead Investor in $127.5M Private Placement for Adverum Biotechnologies - Foley & Lardner LLP

Foley & Lardner LLP

Adverum Biotechnologies to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference - GlobeNewswire

GlobeNewswire

Wall Street Breakfast: The Week Ahead

Seeking Alpha